118 related articles for article (PubMed ID: 15976277)
1. European patents. BRCA2 claim faces new challenge.
Marshall E
Science; 2005 Jun; 308(5730):1851. PubMed ID: 15976277
[No Abstract] [Full Text] [Related]
2. Critics question BRCA2 patent decision in Europe.
Steimle S
J Natl Cancer Inst; 2005 Sep; 97(18):1326. PubMed ID: 16174851
[No Abstract] [Full Text] [Related]
3. 'Are you Jewish?'.
New Sci; 2005 Jul 9-15; 187(2507):7. PubMed ID: 16178105
[No Abstract] [Full Text] [Related]
4. Gene patent fight.
New Sci; 2005 Jun 25-Jul 1; 186(2505):7. PubMed ID: 16178103
[No Abstract] [Full Text] [Related]
5. Genetic patent singles out Jewish women.
Abbott A
Nature; 2005 Jul; 436(7047):12. PubMed ID: 16001030
[No Abstract] [Full Text] [Related]
6. Gene patenting--is the pendulum swinging back?
Kesselheim AS; Mello MM
N Engl J Med; 2010 May; 362(20):1855-8. PubMed ID: 20375396
[No Abstract] [Full Text] [Related]
7. Your money or your life.
Westphal SP
New Sci; 2002 Jul; 175(2351):28-33. PubMed ID: 12625339
[No Abstract] [Full Text] [Related]
8. [Predisposition to breast cancer: Europe closes its doors to Myriad Genetics (Salt Lake City)].
Nau JY
Rev Med Suisse; 2007 Oct; 3(128):2320. PubMed ID: 17985613
[No Abstract] [Full Text] [Related]
9. [Gene chips and predictive medicine: Where is gene diagnostics standing today?].
Kaulen H
Dtsch Med Wochenschr; 2003 Jan; 128(5):181-2. PubMed ID: 12596778
[No Abstract] [Full Text] [Related]
10. Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer families.
Kauff ND; Mitra N; Robson ME; Hurley KE; Chuai S; Goldfrank D; Wadsworth E; Lee J; Cigler T; Borgen PI; Norton L; Barakat RR; Offit K
J Natl Cancer Inst; 2005 Sep; 97(18):1382-4. PubMed ID: 16174860
[TBL] [Abstract][Full Text] [Related]
11. [Federal judge and government of the United States against gene patenting].
Cassier M; Stoppa-Lyonnet D
Med Sci (Paris); 2011; 27(6-7):662-6. PubMed ID: 21718652
[No Abstract] [Full Text] [Related]
12. Patents on breast cancer genes are illegal and stymie research, say scientists.
Lenzer J
BMJ; 2009 Nov; 339():b4899. PubMed ID: 19920010
[No Abstract] [Full Text] [Related]
13. Malta provides loophole for breast-cancer screen.
Check E
Nature; 2002 Oct; 419(6909):767. PubMed ID: 12397316
[No Abstract] [Full Text] [Related]
14. Concomitant BRCA1 and BRCA2 gene mutations in an Ashkenazi Jewish woman with primary breast and ovarian cancer.
Spannuth WA; Thaker PH; Sood AK
Am J Obstet Gynecol; 2007 Apr; 196(4):e6-9. PubMed ID: 17403394
[TBL] [Abstract][Full Text] [Related]
15. [Revocation of the BRCA1 patents by the European Office of Patents: a victory over a rights abuse].
Stoppa-Lyonnet D; Lenoir G
Bull Cancer; 2005 Apr; 92(4):410-1. PubMed ID: 15888396
[No Abstract] [Full Text] [Related]
16. Europe pares down double patents on breast-cancer gene.
Abbott A
Nature; 2005 Jan; 433(7024):344. PubMed ID: 15674256
[No Abstract] [Full Text] [Related]
17. Towards more effective and equitable genetic testing for BRCA1 and BRCA2 mutation carriers.
James PA; Harris M; Lindeman GJ; Mitchell G
J Med Genet; 2008 Nov; 45(11):765-6. PubMed ID: 18978334
[No Abstract] [Full Text] [Related]
18. Analysing DNA patents in relation with diagnostic genetic testing.
Verbeure B; Matthijs G; Van Overwalle G
Eur J Hum Genet; 2006 Jan; 14(1):26-33. PubMed ID: 16251898
[TBL] [Abstract][Full Text] [Related]
19. Communicating BRCA1 and BRCA2 genetic test results.
Gadzicki D; Wingen LU; Teige B; Horn D; Bosse K; Kreuz F; Goecke T; Schäfer D; Voigtländer T; Fischer B; Froster U; Welling B; Debatin I; Weber BH; Schönbuchner I; Nippert I; Schlegelberger B;
J Clin Oncol; 2006 Jun; 24(18):2969-70; author reply 2970-1. PubMed ID: 16782939
[No Abstract] [Full Text] [Related]
20. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility.
Wolff TA; Wilson JE
Am Fam Physician; 2006 Nov; 74(10):1759-60. PubMed ID: 17137007
[No Abstract] [Full Text] [Related]
[Next] [New Search]
